Irina Vetter
Irina Vetter
Verified email at
TitleCited byYear
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
RC Coll, AAB Robertson, JJ Chae, SC Higgins, R Muñoz-Planillo, ...
Nature medicine 21 (3), 248, 2015
Conus venom peptide pharmacology
RJ Lewis, S Dutertre, I Vetter, MDJ Christie
Pharmacological reviews 64 (2), 259-298, 2012
Venomics: a new paradigm for natural products-based drug discovery
I Vetter, JL Davis, LD Rash, R Anangi, M Mobli, PF Alewood, RJ Lewis, ...
Amino acids 40 (1), 15-28, 2011
Evolution of separate predation-and defence-evoked venoms in carnivorous cone snails
S Dutertre, AH Jin, I Vetter, B Hamilton, K Sunagar, V Lavergne, ...
Nature communications 5 (1), 1-9, 2014
The μ opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway
I Vetter, BD Wyse, GR Monteith, SJ Roberts-Thomson, PJ Cabot
Molecular pain 2, 1744-8069-2-22, 2006
Pathophysiology of chemotherapy-induced peripheral neuropathy
H Starobova, I Vetter
Frontiers in molecular neuroscience 10, 174, 2017
An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1. 6 in peripheral pain pathways
JR Deuis, K Zimmermann, AA Romanovsky, LD Possani, PJ Cabot, ...
PAIN® 154 (9), 1749-1757, 2013
A Bayesian model predicts the response of axons to molecular gradients
D Mortimer, J Feldner, T Vaughan, I Vetter, Z Pujic, WJ Rosoff, K Burrage, ...
Proceedings of the National Academy of Sciences 106 (25), 10296-10301, 2009
Methods used to evaluate pain behaviors in rodents
JR Deuis, LS Dvorakova, I Vetter
Frontiers in molecular neuroscience 10, 284, 2017
Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control
D Kapitzke, I Vetter, PJ Cabot
Therapeutics and clinical risk management 1 (4), 279, 2005
Ciguatoxins activate specific cold pain pathways to elicit burning pain from cooling
I Vetter, F Touska, A Hess, R Hinsbey, S Sattler, A Lampert, M Sergejeva, ...
The EMBO journal 31 (19), 3795-3808, 2012
Therapeutic potential of cone snail venom peptides (conopeptides)
I Vetter, R J Lewis
Current topics in medicinal chemistry 12 (14), 1546-1552, 2012
Selenoether oxytocin analogues have analgesic properties in a mouse model of chronic abdominal pain
AD De Araujo, M Mobli, J Castro, AM Harrington, I Vetter, Z Dekan, ...
Nature communications 5 (1), 1-12, 2014
Characterization of endogenous calcium responses in neuronal cell lines
I Vetter, RJ Lewis
Biochemical pharmacology 79 (6), 908-920, 2010
Pharmacological characterisation of the highly NaV1.7 selective spider venom peptide Pn3a
JR Deuis, Z Dekan, JS Wingerd, JJ Smith, NR Munasinghe, RF Bhola, ...
Scientific reports 7, 40883, 2017
α-Conotoxin ImI incorporating stable cystathionine bridges maintains full potency and identical three-dimensional structure
Z Dekan, I Vetter, NL Daly, DJ Craik, RJ Lewis, PF Alewood
Journal of the American Chemical Society 133 (40), 15866-15869, 2011
Golgi calcium pump secretory pathway calcium ATPase 1 (SPCA1) is a key regulator of insulin-like growth factor receptor (IGF1R) processing in the basal-like breast cancer cell …
DM Grice, I Vetter, HM Faddy, PA Kenny, SJ Roberts-Thomson, ...
Journal of Biological Chemistry 285 (48), 37458-37466, 2010
Axon guidance by growth-rate modulation
D Mortimer, Z Pujic, T Vaughan, AW Thompson, J Feldner, I Vetter, ...
Proceedings of the National Academy of Sciences 107 (11), 5202-5207, 2010
Differential evolution and neofunctionalization of snake venom metalloprotease domains
A Brust, K Sunagar, EAB Undheim, I Vetter, DC Yang, NR Casewell, ...
Molecular & Cellular Proteomics 12 (3), 651-663, 2013
NaV1. 7 as a pain target–from gene to pharmacology
I Vetter, JR Deuis, A Mueller, MR Israel, H Starobova, A Zhang, LD Rash, ...
Pharmacology & therapeutics 172, 73-100, 2017
The system can't perform the operation now. Try again later.
Articles 1–20